台股 » 個股 » 中裕 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

中裕

(4147)
可現股當沖
  • 股價
    84.9
  • 漲跌
    ▲0.4
  • 漲幅
    +0.47%
  • 成交量
    471
  • 產業
    上櫃 生技醫療類股
  • 318人加入追蹤

    立即追蹤

  • 本地時間:14:30(已收盤)

     
中裕 (4147)籌碼相關-華南永昌-虎尾 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

華南永昌-虎尾 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/20084.7000.0084.2001,1360.00%
2025/01/17285.8000.0084.6021,1310.18%
2025/01/1600.00187.6086.50-11,133-0.09%
2025/01/15686.3200.0086.2061,1570.52%
2025/01/14488.3500.0087.3041,1470.35%
2025/01/13592.04193.2089.9041,1320.35%
2025/01/1000.00289.4090.50-21,064-0.19%
2025/01/09587.9000.0087.5051,0140.49%
2025/01/0810.1101.492.4101.5097.207.78720.88%
2025/01/0700.00291.4092.70-2649-0.31%
2025/01/06190.10490.2089.80-3611-0.49%
2024/12/10288.5500.0087.5026150.33%
2024/12/09187.70389.0090.10-2600-0.33%
2024/12/06187.60188.7087.6005730.00%
2024/11/2200.00180.7079.90-1512-0.20%
2024/11/21080.3000.0079.7005110.00%
2024/11/20178.3000.0079.0015150.19%
2024/11/08081.7500.0080.1005220.00%
2024/11/0600.00180.8080.80-1528-0.19%
2024/10/25182.00181.5081.4005670.00%
2024/10/2400.00180.8080.80-1572-0.17%
2024/10/23181.0000.0081.8015700.18%
2024/10/09174.9000.0073.9016220.16%
2024/09/2000.00180.7080.90-1653-0.15%
2024/09/16079.5000.0079.4006670.00%
2024/09/09179.6000.0080.6016970.14%
2024/09/06179.6000.0080.2017020.14%
2024/09/05181.0000.0079.2017110.14%
2024/08/22081.2000.0081.3007590.01%
2024/08/05074.4000.0074.0007340.00%
2024/07/22387.50290.4087.1017450.13%
2024/07/19588.52191.0086.5047270.55%
2024/07/18187.7000.0088.4017090.14%
2024/07/17187.60388.1388.10-2713-0.28%
2024/07/03187.40188.0087.4009530.00%
2024/07/02189.0000.0088.6019920.10%
2024/07/0100.00190.4090.20-11,096-0.09%
2024/06/27189.9000.0089.4011,1190.09%
2024/06/2600.00289.4089.50-21,123-0.18%
2024/06/25186.9000.0087.8011,1210.09%
2024/06/24287.6500.0086.7021,1280.18%
2024/06/21288.8500.0088.9021,1210.18%
2024/06/19289.9500.0089.5021,1360.18%
2024/06/1800.00391.9392.00-31,140-0.26%
2024/06/12191.00191.2091.0001,1740.00%
2024/06/11292.15392.4391.00-11,182-0.08%
2024/06/07188.40190.3090.1001,1670.00%
2024/06/0500.00190.4090.30-11,237-0.08%
2024/05/31188.70289.8090.10-11,420-0.07%
2024/05/30188.60189.9088.6001,4750.00%
2024/05/29189.10290.1089.10-11,511-0.07%
2024/05/2800.00188.5088.70-11,555-0.06%
2024/05/23287.5500.0087.1022,0140.10%
2024/05/2200.00188.9088.50-12,100-0.05%
2024/05/21389.23390.5388.0002,1230.00%
2024/05/1600.00186.5086.90-12,189-0.05%
2024/05/13186.4000.0086.5012,2620.04%
2024/05/07187.1000.0086.7012,3360.04%
2024/05/0600.00188.9088.00-12,331-0.04%
2024/04/2900.000.386.0086.00-0.32,338-0.01%
2024/04/2400.00183.9084.80-12,321-0.04%
2024/04/23182.8000.0082.8012,3280.04%
2024/04/2200.00182.6081.80-12,329-0.04%
2024/04/18387.1000.0086.8032,3570.13%
2024/04/17187.8000.0087.8012,3560.04%
2024/04/16189.3000.0087.9012,3510.04%
2024/04/15190.1000.0090.1012,3420.04%
2024/04/1200.00194.0094.00-12,339-0.04%
2024/04/11195.60194.5095.8002,3490.00%
2024/04/0900.00396.5096.20-32,301-0.13%
2024/04/0800.005.492.5293.00-5.42,236-0.24%
2024/04/036.191.14390.4090.603.12,1950.14%
2024/04/0100.00189.9090.10-12,074-0.05%
2024/03/2800.00388.2088.40-32,045-0.15%
2024/03/26188.60189.6088.1002,0330.00%
2024/03/25288.4500.0087.8022,0270.10%
2024/03/2200.00189.4088.80-12,020-0.05%
2024/03/21188.5000.0088.6012,0140.05%
2024/03/19190.7000.0091.1011,9880.05%
2024/03/180.692.2000.0091.300.61,9810.03%
2024/03/15592.2000.0090.1051,9700.25%
2024/03/1400.001291.1391.70-121,960-0.61%
2024/03/131090.65292.3090.9081,9470.41%
2024/03/12191.501292.2391.90-111,944-0.57%
2024/03/1112.194.2000.0094.1012.11,9070.63%
2024/03/082.197.2300.0096.802.11,8650.11%
2024/03/071106.003106.17107.50-21,797-0.11%
2024/03/063105.505102.30103.50-21,735-0.12%
2024/03/050.2107.316107.75102.50-5.81,704-0.34%
2024/03/045109.505110.00109.0001,6410.00%
2024/03/013107.833109.00109.0001,6020.00%
2024/02/294.1108.5100.00110.504.11,5590.26%
2024/02/273.3114.096.5113.96114.00-3.21,413-0.23%
2024/02/260105.0016108.16108.00-161,247-1.28%
2024/02/231103.001102.50102.5001,1070.00%
2024/02/221396.3000.0096.30131,0191.27%
2024/02/21794.6600.0094.8071,0050.70%
2024/02/2000.00194.9096.30-1979-0.10%
2024/02/1900.00293.4093.00-2952-0.21%
中裕長效型愛滋療法2a臨床全數完成注射 今年底至明年初可獲初步結果Anue鉅亨-2024/08/30
中裕與沙國藥廠簽抗愛滋病新藥中東、北非獨家銷售合約UDN聯合新聞網-2024/03/14
中裕 相關文章